Hypervalent Iodine Mediated Efficient Solvent-Free Regioselective Halogenation and Thiocyanation of Fused N-Heterocycles

Divakar Reddy Indukuri; Gal Reddy Potuganti; Manjula Alla

doi:10.1055/s-0037-1611856

Synlett, Table of Contents

Synlett 2019; 30(13): 1573-1579
DOI: 10.1055/s-0037-1611856

letter

Hypervalent Iodine Mediated Efficient Solvent-Free Regioselective Halogenation and Thiocyanation of Fused N-Heterocycles

Divakar Reddy Indukuri

^aFlouro & Agrochemicals Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India

^bAcademy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India Email: manjula@iict.res.in

,

Gal Reddy Potuganti

^aFlouro & Agrochemicals Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India

^bAcademy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India Email: manjula@iict.res.in

,

Manjula Alla*

^aFlouro & Agrochemicals Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India

^bAcademy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India Email: manjula@iict.res.in

› Author Affiliations

Abstract

All articles of this category

Abstract

A facile, rapid, metal-free regioselective halogenation and thiocyanation of imidazo[1,2-a]pyridine/pyrimidine heterocycles has been achieved under solvent-free reaction conditions. Halogenations and thiocyanation of the heterocycles could be accomplished by simple grinding of reactants and hypervalent iodine reagents with the corresponding alkali metal or ammonium salts. The method has been extrapolated to a cleaner synthesis of brominated imidazo[1,2-a]pyridine/pyrimidine derivatives, starting from the corresponding heterocyclic amines and substituted α-bromoketones, utilising HBr generated in situ as the source of bromine.

Key words

solvent free - grinding - regioselective substitution - in situ bromination - atom economy

Full Text

References

References and Notes

1a Feng S, Hong D, Wang B, Zheng X, Miao K, Wang L, Yun H, Gao L, Zhao S, Shen HC. ACS Med. Chem. Lett. 2015; 6: 359
1b Gueiffier E, Gueiffier A. Mini-Rev. Med. Chem. 2007; 7: 888
1c Dyminska L. Bioorg. Med. Chem. 2015; 23: 6087

2a Sharma S, Saha B, Sawant D, Kundu B. J. Comb. Chem. 2007; 9: 783
2b Shono H, Ohkawa T, Tomoda H, Mutai T, Araki K. ACS Appl. Mater. Interfaces 2011; 3: 654

3a Stasyuk AJ, Banasiewicz M, Cyranski MK, Gryko DT. J. Org. Chem. 2012; 77: 5552
3b Shao N, Pang G.-X, Yan C.-X, Sci G.-F, Cheng Y. J. Org. Chem. 2011; 76: 7458
3c Douhal A, Amat-Guerri F, Acuna AU. J. Phys. Chem. 1995; 99: 76
3d Douhal A, Amat-Guerri F, Acuna AU. Angew. Chem. Int. Ed. Engl. 1997; 36: 1514

4a Zhang H, Wei Q, Wei S, Qu J, Wang B. Eur. J. Org. Chem. 2016; 3373
4b Bagdi AK, Hajra A. Chem. Rec. 2016; 16: 1868
4c Xiang S, Chen H, Liu Q. Tetrahedron Lett. 2016; 57: 3870
4d Dey A, Singsardar M, Sarkar R, Hajira A. ACS Omega 2018; 3: 3513
4e Li J, Tang J, Wu Y, He Q, Yu Y. RSC Adv. 2018; 8: 5058
4f Rashmi S, Chitrakar R, Rahul K, Ramavatar M, Subbarayappa A. J. Org. Chem. 2019; 84: 792

5a Xuan Q, Song Q. Org. Lett. 2016; 18: 4250
5b Wu W, Ding Y, Xie P, Tang Q, Pittman CU. Jr, Zhou A. Tetrahedron 2017; 73: 2151
5c Ravi C, Reddy NN. K, Pappula V, Samanta S, Adimurthy S. J. Org. Chem. 2016; 81: 9964
5d Jiao J, Xu L, Zheng W, Xiong P, Hu M.-L, Tang R.-Y. Synthesis 2017; 49: 1839
5e Qi Z, Yu S, Li X. J. Org. Chem. 2015; 80: 3471
5f Sun K, Mu S, Liu Z, Feng R, Li Y, Panga K, Zhang B. Org. Biomol. Chem. 2018; 16: 6655

6a Wang S, Huang X, Ge Z, Wang X, Li R. RSC Adv. 2016; 6: 63532
6b Wang Y, Frett B, McConnella N, Li H. Org. Biomol. Chem. 2015; 13: 2958
6c Zhang J.-R, Zhan L.-Z, Wei L, Ning Y.-Y, Zhong X.-L, Lai J.-X, Xu L, Tang R.-Y. Adv. Synth. Catal. 2018; 360: 533
6d Falck JR, Gao S, Prasad RN, Koduru SR. Bioorg. Med. Chem. Lett. 2008; 18: 1768
6e Mitra S, Ghosh M, Mishra S, Hajra A. J. Org. Chem. 2015; 80: 8275

7a Hari DP, Caramenti P, Waser J. Acc. Chem. Res. 2018; 51: 3212
7b Moriyama K, Izumisawa Y, Togo H. J. Org. Chem. 2011; 76: 7249
7c Huang Z.-Z, Yu X.-C, Huang X. Tetrahedron Lett. 2002; 43: 6823
7d Shneider OS, Pisarevsky E, Fristrup P, Szpilman AM. Org. Lett. 2015; 17: 282
7e Daniel M, Blanchard F, Nocquet-Thibault S, Cariou K, Dodd RH. J. Org. Chem. 2015; 80: 10624
7f Zhao Z, Peng Z, Zhao Y, Liu H, Li C, Zhao J. J. Org. Chem. 2017; 82: 11848
7g Shen H, Li J, Liu Q, Pan J, Huang R, Xiong Y. J. Org. Chem. 2015; 80: 7212

8a Gottam H, Vinod KT. J. Org. Chem. 2011; 76: 974
8b Zhang J, Szabó JK, Himo F. ACS Catal. 2017; 7: 1093
8c Kiyokawa K, Yahata S, Kojima T, Minakata S. Org. Lett. 2014; 16: 4646
8d Desjardins S, Andrez J, Canesi S. Org. Lett. 2011; 13: 3406

9a Fang C, Qian W, Bao W. Synlett 2008; 2529
9b Moteki SA, Usui A, Selvakumar S, Zhang T, Maruoka K. Angew. Chem. Int. Ed. 2014; 53: 11060

10a Sun X, Lyu Y, Zhang-Negrerie D, Du Y, Zhao K. Org. Lett. 2013; 15: 6222
10b Yang Y.-D, Azuma A, Tokunaga E, Yamasaki M, Shiro M, Shibata N. J. Am. Chem. Soc. 2013; 135: 8782
10c Mandha SR, Alla M, Bommena VR, Nanubolu JB, Lingala SK, Yarasi S. J. Org. Chem. 2012; 77: 10648

11a Yusubov MS, Wirth T. Org. Lett. 2005; 7: 519
11b Han H, Tsarevsky NV. Chem. Sci. 2014; 5: 4599
11c Ochiai M, Sueda T, Miyamoto K, Kiprof P, Zhdankin VV. Angew. Chem. Int. Ed. 2006; 45: 8203
11d Sajith PK, Suresh CH. Inorg. Chem. 2012; 51: 967

12a Shakoor SM. A, Mandal SK, Sakhuja R. Eur. J. Org. Chem. 2017; 2596
12b Karade NN, Tiwari GB, Shirodkar SG, Dhoot BM. Synth. Commun. 2005; 35: 1197
12c Chen Z, Cao G, Zhang F, Li H, Xu J, Miao M, Ren H. Synlett 2017; 28: 1795
12d Rahaman R, Das S, Barman P. Green Chem. 2018; 20: 141
12e Mondal S, Samanta S, Jana S, Hajra A. J. Org. Chem. 2017; 82: 4504
12f Yagyu T, Takemoto Y, Yoshimura A, Zhdankin VV, Saito A. Org. Lett. 2017; 19: 2506
12g Xu D, Sun W, Xie Y, Liu J, Liu B, Zhou Y, Wu B. J. Org. Chem. 2016; 81: 11081
12h Zhang X, Hou W, Zhang-Negrerie D, Zhao K, Du Y. Org. Lett. 2015; 17: 5252

13 Synthesis of 3-Halo/thiocyanato-2-phenylimidazo[1,2-a]pyridine Derivatives; General Procedure A mixture of 2-phenylimidazo[1,2-a]pyridine (1; 1 mmol), M-X (2a–d; 1.5 mmol) and IBD (1.5 mmol) were taken in a mortar and the mixture was ground with a pestle until the solids melted (ca. 15 min). A distinction odour of acetic acid was noted. The progress of the reaction was monitored by TLC and grinding was continued until the starting materials disappeared. The reaction mixture was extracted with ethyl acetate (30 mL) and washed with water (10 mL) to remove remnant inorganic salts. The organic layer was separated and dried over Na₂SO₄. Solvent was removed in vacuo. The crude product thus obtained was purified by column chromatography for all halogenations (silicon 60–120 mesh; EtOAc/hexane, 5:95). Thiocyanation products could be obtained in pure form without further purification.
14 Synthesis of 3-Bromo-2-phenylimidazo[1,2-a]pyridine/pyrimidine/benzo[d]imidazo[2,1-b]thiazole Derivatives via in Situ Bromination; General Procedure A mixture of heterocyclic hydrobromide (9/11; 1 mmol), and IBD (1.5 mmol) were taken in a mortar and the mixture was ground with a pestle until the solids melted (ca. 15 min). The progress of the reaction was monitored by TLC and grinding was continued until the starting materials disappeared. The solid residue was washed with n-pentane and dried under high vacuum to afford the product

15a Selvakumar S, Kang Q.-K, Arumugam N, Almansour AI, Kumar RS, Maruoka K. Tetrahedron 2017; 73: 5841
15b Zhao F, Sun T, Sun H, Xi G, Sun K. Tetrahedron Lett. 2017; 58: 3132
15c Wang X, Studer A. Acc. Chem. Res. 2017; 50: 1712
15d Wang X, Studer A. Acc. Chem. Res. 2017; 50: 1712
15e Bose DS, Idrees M. J. Org. Chem. 2006; 71: 8261

16a Yoshimura A, Middleton KR, Todora AD, Kastern BJ, Koski SR, Maskaev AV, Zhdankin VV. Org. Lett. 2013; 15: 4010
16b Boye AC, Meyer D, Ingison CK, French AN, Wirth T. Org. Lett. 2003; 5: 2157

17a Tang S.-Z, Zhao W, Chen T, Liu Y, Zhang X.-M, Zhang F.-M. Adv. Synth. Catal. 2017; 359: 4177
17b Akula R, Galligan M, Ibrahim H. Chem. Commun. 2009; 6991

18 Analytical data and copies of spectra of all compounds are given in the Supporting Information. Analytical data of a selection of new compounds are given below. 3-Bromo-2-(4-methoxyphenyl)-7-methylimidazo[1,2-a]pyridine (3c) Yield: 253 mg (80%); yellow solid; mp 92–94 °C; ¹H NMR (500 MHz, CDCl₃): δ = 8.08–8.04 (m, 1 H), 8.02 (d, J = 7.0 Hz, 1 H), 7.38 (s, 1 H), 7.03–6.99 (m, 2 H), 6.74 (dd, J = 7.0, 1.5 Hz, 1 H), 3.86 (s, 3 H), 2.42 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 159.57, 145.52, 141.94, 136.15, 129.02, 125.35, 122.96, 115.65, 115.50, 113.81, 89.96, 77.00, 55.24, 21.28. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₅H₁₄BrN₂O: 317.0284; found: 317.0290. 3-Bromo-7-methyl-2-(p-tolyl)imidazo[1,2-a]pyridine (3l) Yield: 234 mg (78%); white solid; mp 176–178 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.00 (dd, J = 7.5, 5.8 Hz, 3 H), 7.37 (s, 1 H), 7.29–7.25 (m, 2 H), 6.70 (dd, J = 7.0, 1.5 Hz, 1 H), 2.40 (s, 6 H). ¹³C NMR (125 MHz, CDCl₃): δ = 145.64, 142.27, 137.95, 136.02, 130.04, 129.08, 127.60, 122.98, 115.81, 115.49, 90.41, 77.00, 21.28. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₅H₁₄BrN₂: 301.0348; found: 301.0340. 3-Bromo-2-(thiophen-2-yl)imidazo[1,2-a]pyrimidine (3m) Yield: 232 mg (84%); white solid; mp 150–152 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.56 (dd, J = 4.0, 1.8 Hz, 1 H), 8.40 (dd, J = 6.8, 1.8 Hz, 1 H), 7.95 (d, J = 3.6 Hz, 1 H), 7.45 (d, J = 5.0 Hz, 1 H), 7.20–7.14 (m, 1 H), 6.99 (dd, J = 6.8, 4.1 Hz, 1 H). ¹³C NMR (125 MHz, CDCl₃): δ = 150.23, 147.99, 140.28, 135.12, 131.15, 127.74, 127.28, 126.71, 109.36, 89.31, 77.00. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₀H₇BrN₃S: 279.9543; found: 279.9544. 3-Bromo-2-(3-nitrophenyl)imidazo[1,2-a]pyrimidine (3n) Yield: 214 mg (68%); white solid; mp 224–226 °C; ¹H NMR (300 MHz, CDCl₃+DMSO): δ = 9.12 (s, 1 H), 8.67 (dd, J = 4.1, 1.9 Hz, 1 H), 8.65–8.57 (m, 2 H), 8.27 (dd, J = 8.2, 1.2 Hz, 1 H), 7.72 (t, J = 8.0 Hz, 1 H), 7.15 (dd, J = 6.8, 4.1 Hz, 1 H). ¹³C NMR (75 MHz, CDCl₃+DMSO): δ = 150.36, 147.28, 147.06, 139.91, 133.11, 132.40, 131.32, 128.71, 122.07, 121.29, 109.15, 90.40, 77.00. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₂H₈BrN₄O₂: 317.9749; found: 317.9752. 3-Bromo-7-methyl-2-(p-tolyl)imidazo[1,2-a]pyrimidine (3p) Yield: 241 mg (80%); brown solid; mp 180–182 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.28 (d, J = 7.0 Hz, 1 H), 8.14–8.10 (m, 2 H), 7.29 (d, J = 8.0 Hz, 2 H), 6.85–6.82 (m, 1 H), 2.66 (s, 3 H), 2.41 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 160.32, 148.05, 143.39, 138.52, 130.58, 129.60, 129.13, 127.73, 110.08, 88.91, 77.00, 24.84, 21.35. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₃H₁₁BrN₃: 288.0140; found: 288.0136. HRMS-ESI: m/z [M + H]⁺, calcd. for C₁₄H₁₃BrN₃: 302.0293; found: 302.0287. 3-Bromo-2-(4-methoxyphenyl)imidazo[1,2-a]pyrimidine (3q) Yield: 249 mg (82%); white solid; mp 154–156 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.57 (dd, J = 4.1, 2.0 Hz, 1 H), 8.45 (dd, J = 6.8, 2.0 Hz, 1 H), 8.22–8.16 (m, 2 H), 7.05–6.96 (m, 3 H), 3.88 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 160.16, 149.79, 148.14, 144.22, 131.18, 129.44, 124.79, 113.95, 109.14, 89.38, 77.00, 55.33. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₃H₁₀BrN₃O: 304.0086; found: 304.0085. 3-Bromo-7-methoxy-2-(4-methoxyphenyl)benzo[d]imidazo [2,1-b]thiazole (12b) Yield: 251 mg (65%); white solid; mp 206–208 °C; ¹H NMR (300 MHz, CDCl₃): δ = 8.30 (d, J = 9.1 Hz, 1 H), 7.94 (d, J = 8.8 Hz, 2 H), 7.20 (d, J = 2.4 Hz, 1 H), 7.05–6.92 (m, 3 H), 3.87 (d, J = 4.5 Hz, 6 H). ¹³C NMR (100 MHz, CDCl₃): δ = 159.34, 157.31, 147.08, 143.31, 131.54, 128.46, 127.18, 125.18, 114.26, 113.87, 113.06, 108.54, 90.89, 77.00, 55.88, 55.31. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₇H₁₄BrN₂O₂S: 388.9958; found: 388.9959. 3-Bromo-7-methoxy-2-(p-tolyl)benzo[d]imidazo[2,1-b]thiazole (12c) Yield: 260 mg (70%); pale-pink solid; mp 204–206 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.31 (d, J = 9.1 Hz, 1 H), 7.90 (d, J = 8.2 Hz, 2 H), 7.26 (t, J = 4.0 Hz, 2 H), 7.20 (d, J = 2.4 Hz, 1 H), 7.01 (dd, J = 9.0, 2.4 Hz, 1 H), 3.88 (s, 3 H), 2.40 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 157.27, 147.20, 143.74, 137.63, 131.56, 129.96, 129.11, 127.22, 126.99, 114.26, 112.96, 108.54, 91.33, 77.00, 55.86, 21.31. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₇H₁₄BrN₂OS: 372.9967; found: 372.9954. 3-Chloro-2-(4-methoxyphenyl)-7-methylimidazo[1,2-a]pyridine (4c) Yield: 155 mg (57%); brown solid; mp 122–124 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.09–8.04 (m, 2 H), 7.97 (d, J = 7.0 Hz, 1 H), 7.39 (s, 1 H), 7.03–6.98 (m, 2 H), 6.75 (dd, J = 7.0, 1.5 Hz, 1 H), 3.87 (s, 3 H), 2.43 (d, J = 0.6 Hz, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 159.60, 143.98, 139.23, 135.94, 128.75, 125.19, 121.82, 115.80, 115.45, 113.99, 104.16, 55.34, 21.41. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₅H₁₄OClN₂: 273.0792; found: 273.0789. 3-Iodo-2-(4-methoxyphenyl)-7-methylimidazo[1,2-a]pyridine (5c) Eluent: hexane/ethyl acetate, 90:10. Yield: 254 mg (70%); white solid; mp 118–120 °C; ¹H NMR (400 MHz, CDCl₃): δ = 8.06 (d, J = 7.0 Hz, 1 H), 8.00 (d, J = 8.7 Hz, 2 H), 7.35 (s, 1 H), 7.01 (d, J = 8.7 Hz, 2 H), 6.73 (d, J = 6.9 Hz, 1 H), 3.86 (s, 3 H), 2.43 (s, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 159.56, 148.23, 147.52, 136.37, 129.59, 126.16, 125.43, 115.71, 115.45, 113.66, 77.00, 57.33, 55.22, 21.19. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₅H₁₄IN₂O: 365.0146; found: 365.0151. 3-Thiocyanato-2-(p-tolyl)imidazo[1,2-a]pyrimidine (6g) Yield: 223 mg (84%); white solid; mp 208–210 °C; ¹H NMR (300 MHz, CDCl₃+DMSO): δ = 8.81 (ddd, J = 6.1, 5.5, 1.9 Hz, 2 H), 8.07 (d, J = 8.2 Hz, 2 H), 7.37 (d, J = 8.0 Hz, 2 H), 7.27 (dd, J = 6.7, 4.3 Hz, 1 H), 2.46 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃+DMSO): δ = 151.94, 138.92, 131.87, 128.45, 127.67, 126.76, 109.65, 77.00, 20.38. HRMS-ESI: m/z [M + H]⁺ calcd. for C₁₄H₁₁IN₄S: 267.0695; found: 267.0699.

Supplementary Material

Supporting Information